TrialThe Journal of clinical investigation2021

Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice.

Sara A Healy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.